What is SentiAR?
SentiAR is a venture-backed software device spinout developing a 3D visualization platform for interventional surgeries. Spun out of WashU in 2017, the company’s holographic platform will initially be used in catheter ablation procedures treating cardiac arrhythmia. SentiAR intends to submit a 510(k) application in 2018.
Company Leadership
Jon Silva
Co-Founder & CTO
Jon created the SentiAR visualization platform and has oversight for the
overall technical design and development to meet current and future
clinical applications. It was his original work that secured over
$500,000 in grants to build the initial prototype on the Microsoft
Hololens platform for in-human engineering trials. As an Asst. Professor
of Biomedical Engineering at Washington University in St. Louis, his
research laboratory specializes in applying computational approaches to
address problems in cardiac electrophysiology. Jonathan is part of the
Cardiac Bioelectricity and Arrhythmia Center, and his academic
preparation includes a BS from Johns Hopkins University, an MS from Case
Western Reserve University, and a PhD in Biomedical Engineering,
Washington University.
Jennifer Avari Silva
Co-Founder & CMO
Jennifer Avari Silva is responsible for the clinical application of the
SentiAR technology for patient use. She is an Asst. Professor of
Pediatrics at Washington University in St. Louis and Director of
Pediatric Cardiac Electrophysiology at St. Louis Children’s Hospital,
where she leads the largest pediatric electrophysiology program in the
Midwest. Dr. Avari Silva has published numerous papers bringing new
technologies to pediatric patients, allowing her to develop an extensive
industrial network with companies that include, St. Jude Medical,
Medtronic, Biotronik, and Biosense Webster.
Mike Southworth
lead developer & Co-founder
Michael is responsible for the company’s holographic platform
validation, software planning, and team execution. Prior to joining the
project, he developed 3D computer vision exploitation of sensor data for
use in airborne platforms as an electrophysics scientist at Boeing
Research and Technology. From 2007-2015 at the Johns Hopkins University
Applied Physics Laboratory (JHUAPL), Michael specialized in the rapid
development of embedded systems for direct deployment to the Department
of Defense end users, primarily focused on the technical integration of
wireless embedded systems with emerging microelectromechanical systems
(MEMS) sensor technology, navigation, electro-optical sensor development
and 3D sensor exploitation. Michael earned his BS from UC Berkeley and a
dual MS from Johns Hopkins University.
Berk Tas
CEO & President
Berk Tas serves as the Chief Executive Officer and President of SentiAR.
Berk has led development of emerging technologies and companies in
Fortune 500, private equity, venture capital funded and privately held
organizations. Prior to joining SentiAR he led the development of a
novel Trans-aortic Valve Replacement technology into CE Mark studies at
HLT Medical. In 2016, he played an integral role in the acquisition of
Sensium, Oxford UK, a novel wireless monitoring technology. Prior to
that he served in various leadership roles at Sunshine Heart developing
a first of its kind, heart failure therapy and at Boston Scientific
developing several novel therapies and technologies focused in Cardiac
Rhythm Management. He holds an MBA from the Carlson School of Business
at the University of Minnesota and a BS in Electrical Engineering and
Physics from the School of Engineering at St Thomas University.
Involved Industries
Be a Part of the Movement
We champion extraordinary entrepreneurs to create positive change – for St. Louis and for the world. Join us by applying to our Global Startup Competition, becoming a financial supporter, volunteering your time or amplifying our message.